Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension

NCT04654650 · tracked via the Priya Life Science Germany tracker

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Phase

Observational

Started

2021-01-26

Last updated

2024-12-20

Condition(s) studied

Pulmonary Hypertension

Study summary

Prospective registry and biobank for long-term observational studies in adult patients with pulmonary hypertension

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Diagnosis of pulmonary hypertension group 1 to 5 * Ability to give informed consent Exclusion Criteria: \- Withdrawal of informed consent

Primary outcome measure(s)

Transplant-free survival — Up to 20 years of follow-up after enrollment

Trial sites (1)

Facility	City	Region	Status
Universitätsklinikum Hamburg-Eppendorf	Hamburg	Free and Hanseatic City of Hamburg	Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

External Validation of the MASCAN Score for the Classification of Difficult Mask Ventilation Recruiting

Characterisation of phenotYpes in aCute Heart faiLure patiEnts Recruiting

Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD Active, not recruiting

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor Recruiting

The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R) Recruiting

Other trials for the same condition

PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension Recruiting

Giessen Pulmonary Hypertension Registry and Biobank Recruiting

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure Recruiting

Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial Recruiting

Diaphragmatic Function as a Biomarker Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04654650 on ClinicalTrials.gov ↗ ← All trials in Germany